Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Micronoma
AddedFeb 15, 2024
UpdatedJun 18, 2026
Micronoma

Micronoma

Series A

Micronoma, a pioneer in liquid biopsy technology, accurately detects and predicts early-stage cancer.

HQ
San Diego, CA, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Micronoma, founded by leaders in microbiome research, is a pioneering company in liquid biopsy technology aimed at early cancer detection. The company's core mission is to improve lives by providing clinical-grade accuracy in detecting and predicting cancer through the interrogation of microbial signals. Micronoma focuses on utilizing microbiome markers in blood samples to identify early-stage cancer, offering a non-invasive and highly precise diagnostic tool.

Notable figures affiliated with Micronoma include its founders, who are recognized experts in microbiome research. The company has attracted significant attention from investors due to its innovative approach and potential impact on early cancer diagnosis. Key achievements include the development of a proprietary platform that leverages microbiome markers for cancer detection. Overall, Micronoma's work promises to revolutionize the field of oncology diagnostics, offering earlier and more accurate detection methods that could significantly improve patient outcomes.

Micronoma - Similar Companies

Droplet Biosciences logo

Droplet Biosciences

dropletbiosci.com

Freenome logo

Freenome

freenome.com

Epinoma logo

Epinoma

epinoma.com

Biomiic logo

Biomiic

Mercy BioAnalytics logo

Mercy BioAnalytics

mercybio.com

Oncodea logo

Oncodea

oncodea.com

Foresight Diagnostics logo

Foresight Diagnostics

foresight-dx.com

Thrive Earlier Detection logo

Thrive Earlier Detection

Lucence logo

Lucence

lucence.com

AOA Dx logo

AOA Dx

aoadx.com

GRAIL logo

GRAIL

grail.com

Acuamark Diagnostics logo

Acuamark Diagnostics

acuamarkdx.com

Matrix-Bio logo

Matrix-Bio

Naveris logo

Naveris

naveris.com

MeCo Diagnostics logo

MeCo Diagnostics

Micronoma - Quick Facts

Who are Micronoma's competitors?

Companies similar to Micronoma include Droplet Biosciences, Freenome, Epinoma and Biomiic.

When was Micronoma founded?

Micronoma was founded in 2019.

Where is Micronoma's headquarters located?

Micronoma's headquarters is located in San Diego, CA, US.

When was Micronoma's last funding round?

Micronoma's most recent funding round was for $11M (USD) in March 2022.

How much has Micronoma raised to-date?

As of Mar 31, 2022, Micronoma has raised a total of $17.5M (USD).

How many employees does Micronoma have?

Micronoma has 37 employees as of Feb 4, 2024.

Micronoma - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Cancer Detection
Tags
  • Biotech
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 8 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research